INSIGHTS

CNBC Disruptor 50: ElevateBio CEO Ger Brophy on AI and CRISPR for rare disease

ElevateBio is recognized on ‘Worldwide Exchange’ as #43 on the Disruptor 50 list - discuss new basecamp at Pittsburgh BioForge

‍

Join our Newsletter

Get insights delivered to your inbox.

Download Resource

Enter your email to get access to the resource

View Full Resource

Access directly from its original publisher.

Share

more Resources

News

Aug 2026

Richard King Mellon Foundation Commits Up to $25 Million to Launch Rare Ventures ™, a First-of-its-Kind Platform for Accelerating Rare Disease Therapies

Insights

May 2026

Pittsburgh Is Having the Right Conversation About AI in Healthcare. Now We Have to Do Something About It.

News

Nov 2025

How One Company Aims to Fix the Prosthetic Fitting Process